Type 2 Diabetes

Midlife Strength Training Linked to Lower Diabetes Risk

Midlife Strength Training Linked to Lower Diabetes Risk

Jun 23, 2026

1 min read

Midlife Strength Training Linked to Lower Diabetes Risk

Midlife Strength Training Linked to Lower Diabetes Risk

HealthDay Staff

Jun 23, 2026

2 min read

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

ENDO: More Than Half of Adults With T2DM Who Discontinue GLP-1 Receptor Agonists Reinitiate Treatment

Jun 17, 2026

2 min read

ADA: Orforglipron Beneficial for Reducing HbA1c in Type 2 Diabetes

ADA: Orforglipron Beneficial for Reducing HbA1c in Type 2 Diabetes

Jun 16, 2026

2 min read

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

ENDO: GLP-1 Receptor Agonists Tied to Higher Hypotension Risk in Patients on BP Meds

Jun 15, 2026

1 min read

FDA Approves First Over-the-Counter Glucose Monitor for Children

FDA Approves First Over-the-Counter Glucose Monitor for Children

Jun 15, 2026

3 min read

Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting

Taking GLP-1s While On BP Meds May Up Your Risk Of Dizzy Spells, Fainting

Stephanie Brown

Jun 15, 2026

2 min read

ADA: Once-Weekly Cagrilintide + Semaglutide Promising in Type 2 Diabetes

ADA: Once-Weekly Cagrilintide + Semaglutide Promising in Type 2 Diabetes

Jun 12, 2026

2 min read

FDA Approves Rapid-Acting Inhaled Insulin for Children

FDA Approves Rapid-Acting Inhaled Insulin for Children

Jun 12, 2026

1 min read

Read More

www.healthday.com